Furthermore, ET-1 plays a major role in pulmonary hypertension: there is a significant correlation between the level of ET-1 and the severity of disease [39,40], and ETAR antagonists are the first line drugs in this field. Here, EDNRA is linked to pulmonary arterial hypertension.